Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meagan L Adamsick

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of the American Society of Nephrology : JASN|February 3, 2023
Authors' ReplyMeagan L Adamsick, Roby P Bhattacharyya, Meghan E Sise, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2020
Risk of Serotonin Syndrome with IsoniazidMichael E O'Brien, Ronak G Gandhi, Camille N Kotton, et al.
Journal of the American Pharmacists Association : Japha|September 5, 2022
Pharmacist discharge summary: Impact of inpatient to community pharmacist handoff at hospital dischargeLuiza Kerstenetzky-Brenny, Meagan L Adamsick, Rebecca L Lauscher, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 14, 2019
Therapeutic drug concentrations of isavuconazole following the administration of isavuconazonium sulfate capsules via gastro-jejunum tube: A case reportMeagan L Adamsick, Ramy H Elshaboury, Thais Gift, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 2, 2021
Therapeutic drug monitoring of flucytosine in a cardiac transplant patient receiving continuous veno-venous hemofiltration and intermittent hemodialysis: A case reportKelsey N Williams, Monique R Bidell, Meagan L Adamsick, et al.
Drugs - Real World Outcomes|June 28, 2020
Clinical Outcomes and Economic Impact of Oritavancin for Gram-Positive Infections: A Single Academic Medical Center Health System ExperienceLauren E Brownell, Meagan L Adamsick, Erin K McCreary, et al.
Journal of the American Society of Nephrology : JASN|June 10, 2020
Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19Meagan L Adamsick, Ronak G Gandhi, Monique R Bidell, et al.
Therapeutic Advances in Infectious Disease|September 30, 2021
Remdesivir use and outcomes during the FDA COVID-19 emergency use authorization periodRamy H Elshaboury, Miranda M Monk, Lisa M Bebell, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of the American Society of Nephrology : JASN|February 3, 2023
Authors' ReplyMeagan L Adamsick, Roby P Bhattacharyya, Meghan E Sise, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2020
Risk of Serotonin Syndrome with IsoniazidMichael E O'Brien, Ronak G Gandhi, Camille N Kotton, et al.
Journal of the American Pharmacists Association : Japha|September 5, 2022
Pharmacist discharge summary: Impact of inpatient to community pharmacist handoff at hospital dischargeLuiza Kerstenetzky-Brenny, Meagan L Adamsick, Rebecca L Lauscher, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 14, 2019
Therapeutic drug concentrations of isavuconazole following the administration of isavuconazonium sulfate capsules via gastro-jejunum tube: A case reportMeagan L Adamsick, Ramy H Elshaboury, Thais Gift, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 2, 2021
Therapeutic drug monitoring of flucytosine in a cardiac transplant patient receiving continuous veno-venous hemofiltration and intermittent hemodialysis: A case reportKelsey N Williams, Monique R Bidell, Meagan L Adamsick, et al.
Drugs - Real World Outcomes|June 28, 2020
Clinical Outcomes and Economic Impact of Oritavancin for Gram-Positive Infections: A Single Academic Medical Center Health System ExperienceLauren E Brownell, Meagan L Adamsick, Erin K McCreary, et al.
Journal of the American Society of Nephrology : JASN|June 10, 2020
Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19Meagan L Adamsick, Ronak G Gandhi, Monique R Bidell, et al.
Therapeutic Advances in Infectious Disease|September 30, 2021
Remdesivir use and outcomes during the FDA COVID-19 emergency use authorization periodRamy H Elshaboury, Miranda M Monk, Lisa M Bebell, et al.
Pageof 1